There is no single test that confirms multiple sclerosis. Diagnosis relies on a combination of MRI scans, spinal fluid analysis, neurological exams, and blood tests that together build the case for MS while ruling out conditions that look similar. The process typically starts with an MRI and works outward from there, guided by international standards called the McDonald criteria, which were substantially updated in 2024.
MRI: The Central Test
An MRI of the brain and spinal cord is the most important tool in diagnosing MS. It detects areas of damage, called lesions, where the immune system has attacked the protective coating around nerve fibers. These lesions appear as bright spots on the scan and tend to show up in characteristic locations: the brain’s white matter, the brainstem, the cerebellum, and the spinal cord. Under the 2024 McDonald criteria, the optic nerve now counts as a fifth location, which is new.
For a diagnosis, doctors need to see evidence that damage has occurred in more than one area of the central nervous system (called dissemination in space) and at more than one point in time (dissemination in time). A single MRI can sometimes satisfy both requirements if it shows a mix of older and newer lesions.
A contrast dye, typically gadolinium, is injected through an IV during the scan. Lesions that “light up” with contrast are actively inflamed, while those that don’t are older. This distinction matters because a scan showing both enhancing and non-enhancing lesions can demonstrate that the disease has been active over time, not just in one episode. Most neurologists prefer to start with contrast-enhanced MRI of both the brain and spinal cord as the first diagnostic step.
Lumbar Puncture (Spinal Tap)
A lumbar puncture collects a small sample of cerebrospinal fluid, the liquid surrounding your brain and spinal cord. The lab analyzes it for specific immune markers called oligoclonal bands, which are antibodies produced inside the central nervous system. About 91% of people with confirmed MS test positive for these bands, compared to roughly 10% of people with unrelated conditions. That gap makes the test a strong supporting piece of evidence.
The test is particularly useful when MRI findings are borderline or when symptoms don’t clearly point to MS. Under the updated 2024 criteria, another spinal fluid marker, a protein called kappa free light chains, can also provide supporting evidence for diagnosis. A lumbar puncture isn’t always required if MRI findings are definitive, but it adds confidence when the picture is less clear.
The procedure itself involves a needle inserted into the lower back while you’re curled on your side or sitting hunched forward. It takes about 30 minutes. Some people experience a headache afterward that improves by lying flat and staying hydrated.
Blood Tests to Rule Out Mimics
No blood test can confirm MS, but several are used to eliminate conditions that cause overlapping symptoms. Your doctor will likely order tests for:
- Vitamin B12 deficiency, which causes numbness, tingling, and balance problems that closely resemble MS
- Lyme disease, a tick-borne infection that can produce neurological symptoms and even brain lesions on MRI
- Lupus and Sjögren syndrome, autoimmune diseases that can affect the nervous system
- Syphilis and HIV, infections that occasionally cause MS-like neurological damage
Two conditions deserve special attention because they look very similar to MS on imaging but require completely different treatment. Neuromyelitis optica spectrum disorder (NMOSD) and MOG-associated disorder (MOGAD) both attack the central nervous system, but they respond to different medications and can worsen on some MS treatments. Specific antibody blood tests, particularly one targeting a protein called aquaporin-4, can distinguish NMOSD from MS. These tests are especially important for people of Asian or African American descent, where NMOSD and MOGAD are more common relative to MS.
Evoked Potential Tests
Evoked potential tests measure how fast electrical signals travel along your nerves to your brain. In MS, damaged nerve coatings slow these signals down, sometimes before any symptoms are noticeable. The most commonly used version is the visual evoked potential test: you watch a flashing checkerboard pattern on a screen while electrodes on your scalp record how quickly your brain registers the image. A delayed response suggests damage along the visual pathway, even if your vision seems fine.
A second type, somatosensory evoked potentials, works similarly but tests sensation. Electrodes deliver a mild electrical pulse to your wrist or knee, and scalp electrodes measure how long the signal takes to reach your brain. These tests are painless, take about 30 to 60 minutes, and can provide useful evidence when MRI results don’t tell the full story.
Newer Markers in the 2024 Criteria
The 2024 revision of the McDonald criteria introduced several newer MRI techniques that can strengthen a diagnosis. The central vein sign looks at whether a tiny vein runs through the center of each brain lesion. MS lesions typically form around veins, while lesions from other causes often don’t. Paramagnetic rim lesions, which show a ring of iron-laden immune cells around their edges, are another feature that points specifically toward MS rather than lookalike conditions.
A blood marker called neurofilament light chain (NfL) is also gaining traction. When nerve fibers are damaged, they release this protein into the blood, providing a real-time snapshot of disease activity. It’s noninvasive, inexpensive, and can be measured frequently, making it useful for monitoring over time. However, elevated NfL isn’t specific to MS. Many neurological conditions raise it, so it works better for tracking disease activity and treatment response than for making an initial diagnosis. Routine clinical lab tests for NfL are still in development but expected to become widely available soon.
What the Diagnostic Process Looks Like
The typical path starts with a visit to a neurologist after you’ve experienced symptoms like numbness, vision problems, unusual fatigue, or difficulty with balance. The neurologist performs a physical exam testing your reflexes, coordination, eye movements, and sensation. If MS is suspected, an MRI is ordered first. Depending on those results, a lumbar puncture and blood tests follow. Evoked potentials may be added if imaging is inconclusive.
The updated 2024 criteria were designed to speed up this process. In some cases, a person whose MRI shows characteristic lesions but who hasn’t yet had a clear clinical attack can now meet the criteria for diagnosis, which wasn’t possible under previous rules. This is significant because earlier diagnosis means earlier access to treatment, which slows the accumulation of disability. The criteria also provide specific guidance for diagnosing people over 50 and those with other health conditions that can complicate interpretation.
From first symptoms to confirmed diagnosis, the timeline varies widely. Some people receive a diagnosis within weeks if their MRI and spinal fluid results are clear-cut. Others wait months or longer, particularly if initial symptoms resolve on their own or if lesions don’t yet meet the criteria for dissemination in space and time. In those cases, a follow-up MRI several months later may show new lesions that complete the diagnostic picture.